| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 06/16/2011 | US20110142843 Fetal polypeptides from human liver |
| 06/16/2011 | US20110142841 Compositions and methods for the treatment of systemic lupus erythematosis |
| 06/16/2011 | US20110142838 Novel antibodies against cancer target block tumor growth, angiogenesis and metastatis |
| 06/16/2011 | US20110142825 Glycosylation Engineering of Antibodies for Improving Antibody-Dependent Cellular Cytotoxicity |
| 06/16/2011 | US20110142815 Compounds, composition, methods, targets for cancer therapy |
| 06/16/2011 | US20110142814 Methods for Using Protein Kinase C-Theta Inhibitors in Adoptive Immunotherapy |
| 06/16/2011 | US20110142812 Suppressive macrophages, c-reactive protein and the treatment of systemic lupus erythematosus and immune thrombocytopenic purpura |
| 06/16/2011 | US20110142811 Measles virus for the elimination of unwanted cell populations |
| 06/16/2011 | US20110142810 Cell preparation for bone tissue regeneration |
| 06/16/2011 | US20110142809 Method for separating highly active stem cells from human stem cells and highly active stem cells separated thereby |
| 06/16/2011 | US20110142808 Polymerized Hemoglobin Media and Its Use in Isolation and Transplantation of Islet Cells |
| 06/16/2011 | US20110142807 Mesenchymal Stem Cells and Uses Therefor |
| 06/16/2011 | US20110142806 Electroactive Scaffold |
| 06/16/2011 | US20110142799 Modulation of neurodegenerative disease by modulating xbp-1 activity |
| 06/16/2011 | US20110142797 Method For Prophylaxis or Treatment of Feline Infectious Peritonitis |
| 06/16/2011 | US20110142761 Il-1 binding proteins |
| 06/16/2011 | DE102007040370B4 Kollagenhaltiger Zellträger Collagen-cell support |
| 06/16/2011 | CA2820202A1 Method of reversing immune suppression of langerhans cells |
| 06/16/2011 | CA2783876A1 New conjugates and compositions for immunotherapy and antitumoral treatment |
| 06/16/2011 | CA2783550A1 Improved methods of cell culture for adoptive cell therapy |
| 06/16/2011 | CA2783032A1 Rna preparations comprising purified modified rna for reprogramming cells |
| 06/15/2011 | EP2333099A2 Enzymes having alpha amylase activity and methods of use thereof |
| 06/15/2011 | EP2333098A2 Enzymes having alpha amylase activity and methods of use thereof |
| 06/15/2011 | EP2333097A2 Enzymes having alpha amylase activity and methods of use thereof |
| 06/15/2011 | EP2333096A2 Expression of class 2 mannosidase and class III mannosidase in lower eukaryotic cells |
| 06/15/2011 | EP2333095A1 Expression of class 2 mannosidase and class III mannosidase in lower eukaryotic cells |
| 06/15/2011 | EP2333085A1 Dominant gene suppression transgenes and methods of using same |
| 06/15/2011 | EP2333084A1 Dominant gene suppression transgenes and methods of using same |
| 06/15/2011 | EP2333075A1 Dominant gene suppression transgenes and methods of using same |
| 06/15/2011 | EP2333073A1 Schitzochytrium PKS genes |
| 06/15/2011 | EP2333072A1 Schizochytrium PKS genes |
| 06/15/2011 | EP2333071A1 Schitzochytrium PKS genes |
| 06/15/2011 | EP2333069A2 Therapeutic uses of IL-17 homologous polypeptides |
| 06/15/2011 | EP2333065A1 Novel MHC class II restricted T cell epitopes from the cancer antigen, NY ESO-1 |
| 06/15/2011 | EP2333064A1 Nucleotide and protein sequences of Nogo genes and methods based thereon |
| 06/15/2011 | EP2333052A1 Desaturase genes and uses thereof |
| 06/15/2011 | EP2333051A1 Dominant gene suppression transgenes and methods of using same |
| 06/15/2011 | EP2333050A1 B cell-derived ips cells and application thereof |
| 06/15/2011 | EP2333049A1 Pluripotent embryonic-like stem cells, compositions, methods and uses thereof |
| 06/15/2011 | EP2333048A1 PDGF for use in inducing proliferation of a neural progenitor cell that differentiates into neurons and oligodendrocytes by not astrocytes |
| 06/15/2011 | EP2333047A1 Adult stem cell derived conditioned medium and/or adult stem cells for use in the therapeutic treatment of a tumor disease |
| 06/15/2011 | EP2333044A1 Pharmaceutically compatible method for purifying intact bacterial minicells |
| 06/15/2011 | EP2332988A2 Monoclonal antibodies and methods for their use in the detection of cervical disease |
| 06/15/2011 | EP2332983A2 Identification of tumor-associated cell-surface antigens for diagnosis and theapy |
| 06/15/2011 | EP2332982A1 Liver X receptor alpha splicing mutant protein, gene thereof and utilization of the same |
| 06/15/2011 | EP2332981A2 Identification of tumor-associated cell-surface antigens for diagnosis and theapy |
| 06/15/2011 | EP2332980A2 Identification of tumor-associated cell-surface antigens for diagnosis and theapy |
| 06/15/2011 | EP2332979A2 Identification of tumour-associated cell surface antigens for diagnosis and therapy |
| 06/15/2011 | EP2332978A1 Novel polypeptides involved in immune response |
| 06/15/2011 | EP2332976A1 Novel polypeptides involved in immune response |
| 06/15/2011 | EP2332975A1 Human proteins |
| 06/15/2011 | EP2332974A2 Osteoprotegerin |
| 06/15/2011 | EP2332973A2 Differential in tumour gene products and use of same |
| 06/15/2011 | EP2332972A1 Novel Beta-Actin and RPS21 promoters and uses thereof |
| 06/15/2011 | EP2332961A2 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 06/15/2011 | EP2332956A1 Antibody binding to PRO71238 |
| 06/15/2011 | EP2332955A2 Antisense modulation of acyl CoA cholesterol acyltransferase-2 expression |
| 06/15/2011 | EP2332582A1 ACE2 activation for treatment of heart, lung and kidney disease and hypertension |
| 06/15/2011 | EP2332579A2 Antibodies that bind human interleukin-18 and methods of making and using |
| 06/15/2011 | EP2332573A1 Chimeric alphavirus replicon particles |
| 06/15/2011 | EP2332572A1 Nucleic acid vaccines for prevention of Flavivirus |
| 06/15/2011 | EP2332555A2 Methods of using regenerative cells to promote wound healing |
| 06/15/2011 | EP2332492A2 Apparatus and methods for providing sex-sorted animal sperm |
| 06/15/2011 | EP2332405A1 Media comprising gellan gum and methods for promoting maturation of conifer somatic embryos |
| 06/15/2011 | EP2331701A1 Cells producing glycoproteins having altered glycosylation patterns and methods and use thereof |
| 06/15/2011 | EP2331692A1 Modified thromboxane a2 receptor promoter sequence |
| 06/15/2011 | EP2331681A2 Vector for identification, selection and expression of recombinants |
| 06/15/2011 | EP2331680A1 Methods and compositions for generating an immune response by inducing cd40 and pattern recognition receptor adapters |
| 06/15/2011 | EP2331679A1 Ischemic tissue cell therapy |
| 06/15/2011 | EP2331678A1 Methods for obtaining high viable cell density in mammalian cell culture |
| 06/15/2011 | EP2331677A1 High-throughput and non-invasive method to vitrify porcine embryos |
| 06/15/2011 | EP2331676A2 Hematopoietic stem cell growth factor |
| 06/15/2011 | EP2331675A1 Markers of induced pluripotent stem cells |
| 06/15/2011 | EP2331119A1 Malaria vaccine |
| 06/15/2011 | EP2331109A1 Methods and compositions for treatment of bone defects with placental cell populations |
| 06/15/2011 | EP1974020B1 Methods for obtaining immortalized antibody secreting cells |
| 06/15/2011 | EP1881008B1 Method for the in vitro diagnosis of alzheimer's disease using a monoclonal antibody |
| 06/15/2011 | EP1766093B1 Antibodies against clostridium difficile toxins and uses thereof |
| 06/15/2011 | EP1699480B1 Allogeneic tumor therapeutic agent |
| 06/15/2011 | EP1675966B1 Determination of mycoplasma contamination integrated with gene expression profiling of cell cultures using DNA chip technology |
| 06/15/2011 | EP1616000B1 Expression of proteins in cord blood-derived endothelial cells |
| 06/15/2011 | EP1500665B1 METHODS FOR CONSTRUCTING scDb LIBRARIES |
| 06/15/2011 | EP1481061B1 Denaturant stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same and their uses |
| 06/15/2011 | EP1476462B1 Novel fungal lipase |
| 06/15/2011 | EP1417229B1 Methods and compounds for the targeting of protein to exosomes |
| 06/15/2011 | EP1392833B1 Site-targeted transformation using amplification vectors |
| 06/15/2011 | EP1373476B1 Cytochrome p450s and uses thereof |
| 06/15/2011 | EP1012274B2 Death domain containing receptor 4 (dr4: death receptor 4), member of the tnf-receptor superfamily and binding to trail (ap0-2l) |
| 06/15/2011 | EP0939804B2 NEUTROKINE alpha |
| 06/15/2011 | CN1837362B SiRNA for inhibiting expression of SARS coronavirus N protein and encoding gene thereof |
| 06/15/2011 | CN1780907B Anti-CCR5 antibody |
| 06/15/2011 | CN1680432B Viral protein |
| 06/15/2011 | CN1452636B Human monoclonal antibodies to dendritis cells |
| 06/15/2011 | CN102099469A Novel protein having endoglucanase activity, DNA of the protein, and use of the same |
| 06/15/2011 | CN102099468A Anti-system ASC amino acid transporter 2 (ASCT2) antibody |
| 06/15/2011 | CN102099463A Immortal unipotent porcine picm- 19h and picm- 19b stem cell lines |
| 06/15/2011 | CN102099462A Process for providing an assembly of cell microcarriers |
| 06/15/2011 | CN102094035A Expression vector for constructing high-quality bacteriophage antibody library |
| 06/15/2011 | CN102094034A Process for purifying recombinant human Fc fusion pegylated interferon |
| 06/15/2011 | CN102094032A Novel herbicide resistance genes |